First-in-human dose-finding study of venadaparib (IDX-1197), a potent and selective PARP inhibitor, in patients with advanced solid tumors.
暂无分享,去创建一个
Sung-Bae Kim | C. Ock | K. Bae | Kyungun Kim | N. Baek | Yong-man Kim | Eun-Jihn Roh | W. Lee
暂无分享,去创建一个
Sung-Bae Kim | C. Ock | K. Bae | Kyungun Kim | N. Baek | Yong-man Kim | Eun-Jihn Roh | W. Lee